← Leaderboards
Leigh Goedeke
New York University School Of Medicine
$1,207,972
Attributed
$1,207,972
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2012–24$250K$187.5K$125K$62.5K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,207,972 · 4
By mechanism
R00$747,000 · 1
K99$214,332 · 1
F31$125,228 · 1
F32$121,412 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Ira Jay Goldberg$42,989,404
- Moosa Mohammadi$12,863,599
- Nada A. Abumrad$17,455,079
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoLipidsOxidationInsulin SensitivityInsulinFatty Acid Glycerol EstersMolecularObesityFatty Acid OxidationInsulin ResistanceLiverMetabolismNon-Insulin-Dependent Diabetes MellitusHypertriglyceridemiaMetabolicChronicMetabolic SyndromeCellsCholesterolDyslipidemiasCardiovascular DiseasesAtherosclerosisHepaticGlucose
Grant awards (10)
Cellular and molecular mechanisms of diabetic atherosclerosis$249,000
R00 · FY2024 · HL · contact PI
Cellular and molecular mechanisms of diabetic atherosclerosis$249,000
R00 · FY2023 · HL · contact PI
Cellular and molecular mechanisms of diabetic atherosclerosis$249,000
R00 · FY2022 · HL · contact PI
Cellular and molecular mechanisms of diabetic atherosclerosis$107,166
K99 · FY2021 · HL · contact PI
Cellular and molecular mechanisms of diabetic atherosclerosis$107,166
K99 · FY2020 · HL · contact PI
Effect of Liver-Specific Acetyl-CoA Carboxylase Inhibition on Hepatic Steatosis and Insulin Resistance$64,046
F32 · FY2019 · DK · contact PI
Effect of Liver-Specific Acetyl-CoA Carboxylase Inhibition on Hepatic Steatosis and Insulin Resistance$57,366
F32 · FY2017 · DK · contact PI
MiR-33 and Aging: Implications for Metabolic Syndrome$40,764
F31 · FY2014 · AG · contact PI
MiR-33 and Aging: Implications for Metabolic Syndrome$42,232
F31 · FY2013 · AG · contact PI
MiR-33 and Aging: Implications for Metabolic Syndrome$42,232
F31 · FY2012 · AG · contact PI